The effect of stop smoking on FEV1 and FEV1/FVC

D. M. Suluburic, T. T. Suluburic, N. N. Lazovic, D. M. Kovanovic (Cacak, Yugoslavia)

Source: Annual Congress 2003 - Effect of smoking on COPD
Session: Effect of smoking on COPD
Session type: Thematic Poster Session
Number: 1962
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. M. Suluburic, T. T. Suluburic, N. N. Lazovic, D. M. Kovanovic (Cacak, Yugoslavia). The effect of stop smoking on FEV1 and FEV1/FVC. Eur Respir J 2003; 22: Suppl. 45, 1962

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
FEV6 and FEV1/FEV6 have higher association with small airway function and oxygen saturation than FVC and FEV1/FVC in patients with asthma.
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020

FEV6 and FEV1/FEV6 as an alternative for FVC and FEV1/FVC in monitoring response to prednisolone treatment
Source: Annual Congress 2010 - Quality measurement and improvement in lung function
Year: 2010


Within session variability of FEV1 and FVC pre- and post-bronchodilation
Source: International Congress 2019 – Quality, performance and interpretation of lung function testing
Year: 2019


Midflows do not vary independently of FEV1 and FVC
Source: Annual Congress 2010 - Quality measurement and improvement in lung function
Year: 2010


FEF25-75% should not yet be used to define a bronchodilator response in individuals
Source: Annual Congress 2005 - Spirometry - now and in the future
Year: 2005


Distinguishing hyperinflation from combined restriction in patients with reduced FEV1/FVC and FVC on spirometry
Source: Eur Respir J 2006; 28: Suppl. 50, 202s
Year: 2006

Has the determination of the rate of decline of FEV1 added value in addition to the determination of FEV1/FVC and FEV1
Source: International Congress 2016 – Man versus machine: waves, frequency, and more in lung function
Year: 2016


The influence of FVC manoeuvres on consecutive FEV1 values during methacholine challenge
Source: Eur Respir J 2004; 24: Suppl. 48, 587s
Year: 2004

Raised FeNO is associated with lower FEV1 and FEV1/FVC in children with asthma
Source: International Congress 2019 – Paediatric asthma: risk factors, biomarkers and the basics
Year: 2019


FEV1 decline in occupational asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 488s
Year: 2003

Reference values for FEV1, FVC and FEV1/FVC in Norway
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015

1 year RV/TLC change as a predictor of long term decline of FEV1
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018

Re-assessing the importance of FEV1 decline
Source: Eur Respir Monogr 2015; 69: 134-142
Year: 2015


Annual decline in forced expiratory volume in 1 sec (FEV1) in patients with COPD before and after introduction of tiotropium
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008

Low FEV1/FVC but normal FEV1 in childhood – risk factor or normal variant?
Source: International Congress 2019 – Innovative ways to diagnose and monitor children with lung diseases and sleep-disordered breathing
Year: 2019



The variable relationship between changes in lung density and FEV1 in smokers
Source: International Congress 2017 – Imaging markers for COPD and asthma
Year: 2017

FVC decline over 1 year predicts mortality but not subsequent FVC decline in patients with IPF
Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside
Year: 2017


Maximally attained level of FEV1 and FEV1 decline determine airway hyperresponsiveness in adults
Source: Eur Respir J 2003; 22: Suppl. 45, 17s
Year: 2003

Prediction of all cause mortality in a population sample is improved by using FEV1 quotient
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005